Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.9.4049

Survival Analysis for White Non-Hispanic Female Breast Cancer Patients  

Khan, Hafiz Mohammad Rafiqullah (Department of Biostatistics, Robert Stempel College of Public Health and Social Work Florida International University)
Saxena, Anshul (Department of Health Promotion and Disease Prevention, Robert Stempel College of Public Health and Social Work Florida International University)
Gabbidon, Kemesha (Department of Health Promotion and Disease Prevention, Robert Stempel College of Public Health and Social Work Florida International University)
Stewart, Tiffanie Shauna-Jeanne (Department of Dietetics and Nutrition, Robert Stempel College of Public Health and Social Work Florida International University)
Bhatt, Chintan (Department of Epidemiology, Robert Stempel College of Public Health and Social Work Florida International University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.9, 2014 , pp. 4049-4054 More about this Journal
Abstract
Background: Race and ethnicity are significant factors in predicting survival time of breast cancer patients. In this study, we applied advanced statistical methods to predict the survival of White non-Hispanic female breast cancer patients, who were diagnosed between the years 1973 and 2009 in the United States (U.S.). Materials and Methods: Demographic data from the Surveillance Epidemiology and End Results (SEER) database were used for the purpose of this study. Nine states were randomly selected from 12 U.S. cancer registries. A stratified random sampling method was used to select 2,000 female breast cancer patients from these nine states. We compared four types of advanced statistical probability models to identify the best-fit model for the White non-Hispanic female breast cancer survival data. Three model building criterion were used to measure and compare goodness of fit of the models. These include Akaike Information Criteria (AIC), Bayesian Information Criteria (BIC), and Deviance Information Criteria (DIC). In addition, we used a novel Bayesian method and the Markov Chain Monte Carlo technique to determine the posterior density function of the parameters. After evaluating the model parameters, we selected the model having the lowest DIC value. Using this Bayesian method, we derived the predictive survival density for future survival time and its related inferences. Results: The analytical sample of White non-Hispanic women included 2,000 breast cancer cases from the SEER database (1973-2009). The majority of cases were married (55.2%), the mean age of diagnosis was 63.61 years (SD = 14.24) and the mean survival time was 84 months (SD = 35.01). After comparing the four statistical models, results suggested that the exponentiated Weibull model (DIC= 19818.220) was a better fit for White non-Hispanic females' breast cancer survival data. This model predicted the survival times (in months) for White non-Hispanic women after implementation of precise estimates of the model parameters. Conclusions: By using modern model building criteria, we determined that the data best fit the exponentiated Weibull model. We incorporated precise estimates of the parameter into the predictive model and evaluated the survival inference for the White non-Hispanic female population. This method of analysis will assist researchers in making scientific and clinical conclusions when assessing survival time of breast cancer patients.
Keywords
Breast cancer survival data; statistical probability models; Bayesian inference; predictive inference;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Walker MJ, Mirea L, Cooper K, et al (2013). Impact of familial risk and mammography screening on prognostic indicators of breast disease among women from the Ontario site of the Breast Cancer Family Registry. Fam Cancer, 13, 163-72.
2 Smith RA, Brooks D, Cokkinides V, Saslow D, Brawley OW (2013). Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening. CA Cancer J Clin, 63, 88-105.
3 Sprague BL, Trentham-Dietz A, Gangnon RE, et al (2011). Socioeconomic status and survival after an invasive breast cancer diagnosis. Cancer, 117, 1542-51.   DOI   ScienceOn
4 White A, Richardson LC, Krontiras H, Pisu M (2013). Socioeconomic disparities in breast cancer treatment among older women. J Womens Health (Larchmt), 23, 335-41.
5 WHO (2013a). Cause-specific mortality and morbidity: age-standardized mortality rate by cause by World Bank income group. Geneva: WHO.
6 WHO (2013b). Charts for the 10 leading causes of death for women worldwide and by income group. Geneva: WHO.
7 Wolfram Research (2012). The Mathematica Archive: Mathematica 8.0.
8 Montero AJ, Eapen S, Gorin B, Adler P (2012). The economic burden of metastatic breast cancer: a U.S. managed care perspective. Breast Cancer Res Treat, 134, 815-22.   DOI
9 Khan HMR, Albatineh AN, Alshahrani S, Jenkins N, Ahmed NU (2011). Sensitivity analysis of predictive modeling for responses from the three-parameter Weibull model with a follow-up doubly censored sample of cancer patients. Computational Statistics & Data Analysis, 55, 3093-103.   DOI   ScienceOn
10 Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML (2011). Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst, 103, 117-28.   DOI   ScienceOn
11 MRC Biostatistics Unit (2013). WinBUGS software version 1.4.3: The BUGS Project.
12 Peairs KS, Barone BB, Snyder CF, et al (2011). Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. J Clin Oncol, 29, 40-6.   DOI   ScienceOn
13 Protani M, Coory M, Martin JH (2010). Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat, 123, 627-35.   DOI
14 Robertson A, Ragupathy SK, Boachie C, et al (2011). The clinical effectiveness and cost- effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation. Health Technol Assess, 15, 1-322.
15 SEER. (2010). Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Research Data (1973-2009), National Cancer Institute, DCCPS, Surveillance Research Program. [Accessed July 10, 2013].
16 IBM SPSS (2011). IBM SPSS Statistics for Windows, Version 20.0. Armonk, NY: IBM Corp.
17 Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.   DOI
18 Graeser MK, Engel C, Rhiem K, et al (2009). Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. J Clin Oncol, 27, 5887-92.   DOI   ScienceOn
19 Hou N, Huo D (2013). A trend analysis of breast cancer incidence rates in the United States from 2000 to 2009 shows a recent increase. Breast Cancer Res Treat, 138, 633-41.   DOI   ScienceOn
20 Khan HMR, Saxena A, Shrestha A (2014a). Posterior inference for White Hispanic breast cancer survival data. J Biomet Biostat, 5, 183.
21 Khan HMR, Saxena A, Rana S, Ahmed NU (2014b). Bayesian modeling for male breast cancer data. Asian Pac J Cancer Prev, 15, 663-9.   과학기술학회마을   DOI   ScienceOn
22 Khan HMR, Saxena A, Kemesha G, Rana S, Ahmed NU (2014c). Mode-based survival estimates of female breast cancer data. Asian Pac J Cancer Prev, 15, 2893-900.   과학기술학회마을   DOI   ScienceOn
23 Khan HMR (2012a). Estimating predictive inference for responses from the generalized Rayleigh model based on complete sample. J Thai Statistician, 10, 53-68.
24 Khan HMR (2012b). Several priors based inference from the exponential model under censoring. JP J Fund Appl Stat, 2, 1-13.
25 Khan HMR (2013a). Comparing relative efficiency from a right skewed model. JP J Biostat, 9, 1-26.
26 Barreto-Souza W, Santos AHS, Cordeiro GM (2010). The beta generalized exponential distribution. J Stat Comput Sim, 80, 159-72.   DOI   ScienceOn
27 Khan HMR (2013b). Inferential estimates from the one-parameter half-normal model. J Thai Statistician, 11, 77-95.
28 Clarke CA, Keegan THM, Yang J, et al (2012). Age-specific incidence of breast cancer subtypes: understanding the black-white crossover. J Natl Cancer Inst, 104, 1094-101.   DOI
29 ACS (2013). Cancer Facts and Figures. Atlanta: American Cancer Society. Retrieved from: http://www.cancer.org/research/cancerfactsstatistics/breast-cancer-facts-figures. [Accessed September 15, 2013]
30 CDC (2012). Breast Cancer Rates by Race and Ethnicity. Available at: http://www.cdc.gov/cancer/breast/statistics/race.htm. Accessed June 12, 2012.
31 DeSantis C, Siegel R, Bandi P, Jemal A (2011). Breast cancer statistics. CA Cancer J Clin, 61, 409-18.
32 Gonzalez H, Halevy AY, Jensen CS, et al (2010). Google fusion tables: web-centered data management and collaboration. In Proceedings of the 2010 ACM SIGMOD International Conference on Management of data (pp. 1061.66). New York, NY, USA: ACM.
33 Ferlay J, Soerjomataram I, Ervik M, et al (2013). Cancer Incidence and Mortality Worldwide: IARC Cancer Base. GLOBOCAN 2012, 1 (11). Lyon, France: International Agency for Research on Cancer. Available from: http://globocan.iarc.fr, [Accessed December 20, 2013].
34 Siegel R, Ma J, Zou Z, Jemal A (2014). Cancer statistics, 2014. CA Cancer J Clin, 64, 9-29.   DOI
35 Kwan ML, Kushi LH, Weltzien E, et al (2010). Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol, 28, 4410-6.   DOI   ScienceOn
36 Khan HMR, Saxena A, Kemesha G, Elizabeth R, Alice S (2014d). Statistical applications for White Hispanic breast cancer survival data. Asian Pac J Cancer Prev, [Epub ahead of print].